TrialJAMA ophthalmology2018

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.

Neil M Bressler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.